Systemic Bio Named a Top 10 Finalist for the SLAS 2025 Innovation Award
Provided By GlobeNewswire
Last update: Jan 13, 2025
HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Systemic Bio™, a 3D Systems company (NYSE: DDD), is honored to announce its selection as a Top 10 Finalist for the prestigious SLAS 2025 Innovation Award. This recognition underscores the groundbreaking potential of Systemic Bio’s proprietary h-VIOS™ platform geared at accelerating drug discovery and development using human-relevant data from bioprinted tissues.
Read more at globenewswire.com
